AzTrials
AzTrials

Patient SatisfactionNCT06604559

The Effect of Patient Discharge From the Maternal and Fetal Medicine Unit With Receiving a Discharge Letter Later Using the Apollo App on Discharge Data, Safety and Patient Satisfaction

A study testing Discharge using Apollo application and Regular discharge in people with Patient Satisfaction and Health Care Utilization, run by The Baruch Padeh Medical Center, Poriya at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Women admitted to the maternal and fetal medicine unit are often discharged after a short hospital stay. The routine work in the department is prioritized such that the discharge letter are written. In the last year the Apollo mobile application (app) was introduced. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Patient Satisfaction, Health Care Utilization
What is being tested?
Discharge using Apollo application and Regular discharge
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
1 siteIsrael
Study dates
30 Nov 2024to 5 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Women who are admitted to the maternal and fetal medicine unit with the intention to be discharged before delivery
  • 18 years old and older
  • Consent to participate
  • Owner of a smart phone
  • Consent to download the Apollo app

Who cannot join

  • Delivery during her admission
  • Doesn't own a smart phone
  • Refusal to download to Apollo app
  • Refusal to participate

Trial locations and contacts

1 site in 1 country.

Israel1 site, 1 recruiting
  • Tzafon Medical center, Poriya

    Tiberias, North, 15208

    Enav Yefet, MD/PhD

    Recruiting

Other trials in Israel

About this study

Official title: The Effect of Patient Discharge From the Maternal and Fetal Medicine Unit With Receiving a Discharge Letter Later Using the Apollo App on Discharge Data, Safety and Patient Satisfaction - a Prospective Randomized Controlled Trial

Women admitted to the maternal and fetal medicine unit are often discharged after a short hospital stay. The routine work in the department is prioritized such that the discharge letter are written. In the last year the Apollo mobile application (app) was introduced. It contains general information on the medical center and the maternal and fetal unit department as well as the medical records, laboratory results and summary and discharge letters. The Apollo app is used in the maternal and fetal unit in the discharge process so the patient can receive the discharge letter in the app and does not need to wait until the discharge letter is written.

It is not known whether this process is more effective than the regular discharge process and patients' satisfaction was not assessed previously.

In the present study we will compare discharge data, satisfaction and safety of discharging using the Apollo app versus the routine process.

Being tested
Discharge using Apollo application, Regular discharge
Medical subject headings
Patient Satisfaction, Patient Acceptance of Health Care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Discharge using Apollo applicationOther

    Discharge using Apollo application

  • Regular dischargeOther

    Discharge with the regular process

Study groups in NCT06604559
Study groupRoleWhat they receive
Application dischargeExperimentalThe discharge is conditional on the approval of a senior physician or the attending physician in charge. The participant will sign on a "Form for discharge and consent to receive a discharge letter, using the "Apollo" application" in which the discharge process, recommendations and contact information of the department are described. Thereafter, the patient will be discharge home and the discharge letter will be available in the app once it is written. The participant is guided to contact the department, in case the discharge letter is not received in the application up to 24 hours after discharge.
Receives: Other: Discharge using Apollo application
Regular dischargeOtherThe discharge is conditional on the approval of a senior physician or the attending physician in charge. The patient will go home only after the discharge letter is written.
Receives: Other: Regular discharge

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The mean time needed from discharge decision until the actual discharge

    Measured: up to 24 hours from discharge decision

Secondary outcomes (4)
  1. Satisfaction rate from the discharge method

    Satisfaction rate from the discharge method assessment using a questionnaire

    Measured: Within a week following discharge from the department

  2. The rate of participants with any technical difficulties to receive the discharge letter and reasons

    The rate of participants with any technical difficulties to receive the discharge letter and reasons using a questionnaire

    Measured: Within a week following discharge from the department using a questionnaire

  3. The rate of participants with missed information that required the patient to seek medical help

    The rate of participants with missed information that required the patient to seek medical help using a questionnaire

    Measured: Within a week following discharge from the department using a questionnaire

  4. The rate of participants with discrepancies between the discharge recommendations written in the final discharge letter and the "Form for discharge and consent to receive a discharge letter, using application" and details regarding the discripancies

    Measured: Within a week following discharge from the department

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study start30 Nov 2024 (estimated)
  3. Primary completion5 Aug 2025 (estimated)
  4. Study completion5 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06604559
Sponsor's protocol ID
55-24-POR
Status last verified
Aug 2024
First submitted
11 Aug 2024
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Discharge using Apollo application and Regular discharge in people with Patient Satisfaction and Health Care Utilization, run by The Baruch Padeh Medical Center, Poriya at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Enav Yefet (972-46652306, enavy1@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The mean time needed from discharge decision until the actual discharge (time frame: up to 24 hours from discharge decision). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in